An Osaka University-led research team has recently published findings that provide a ray of hope for the millions of Parkinson’s disease (PD) sufferers worldwide. Although more common in those aged over sixty, PD can strike at any age, with an estimated prevalence of 41 per 100,000 people in their forties. And while not fatal in and of itself, the progressive neurodegeneration that is characteristic of PD can often cause secondary effects that lead to death.
The exact cause of PD is still a mystery, but researchers believe that both genetics and the environment are likely to play a part. Importantly though, all PD patients show a loss of dopaminergic neurons in the brain and increased levels of a protein called ?-synuclein, which accumulates in Lewy bodies. Lewy bodies are a pathological feature of both familial and sporadic forms of the disease, as well as some types of dementia.
In the study published this month in Scientific Reports, the team led by researchers from Osaka University’s Graduate School of Medicine focused on ?-synuclein as a target for a novel PD treatment.
“Although there are drugs that treat the symptoms associated with PD, there is no fundamental treatment to control the onset and progression of the disease,” explains lead author Takuya Uehara. “Therefore, we looked at ways to prevent the expression of ?-synuclein and effectively eliminate the physiological cause of PD.”
To do this, the researchers designed short fragments of DNA that are mirror images of sections of the ?-synuclein gene product. The constructs were stabilized by the addition of amido-bridging. The resulting fragments, called amido-bridged nucleic acid-modified antisense oligonucleotides (ASOs), bind to their matching mRNA sequence, preventing it from being translated into protein. After screening 50 different ASOs, the researchers settled on a 15-nucleotide sequence that decreased ?-synuclein mRNA levels by 81%.
“When we tested the ASO in a mouse model of PD, we found that it was delivered to the brain without the need for chemical carriers,” says co-lead author Chi-Jing Choong. “Further testing showed that the ASO effectively decreased ?-synuclein production in the mice and significantly reduced the severity of disease symptoms within 27 days of administration.”
Explains senior author of the study Hideki Mochizuki, “Our results showed that gene therapy using ?-synuclein-targeting ASOs is a promising strategy for the control and prevention of PD. We expect that in the future, this method will be used to not only successfully treat PD, but also dementia caused by ?-synuclein accumulation.”
Learn more: Stopping Parkinson’s disease before it starts
The Latest on: Parkinson’s disease
via Google News
The Latest on: Parkinson’s disease
- Sharon Osbourne Reveals the Hardest Part of Seeing Ozzy Osbourne Battle Parkinson’s Diseaseon October 7, 2020 at 10:44 am
Sharon Osbourne has been supporting Ozzy Osbourne during his battle with Parkinson’s disease. She revealed the toughest part of dealing with this illness.
- AXGT Reports Parkinson's Trial Data, CRBP Plunges As Cystic Fibrosis Study Fails, GMDA On Trackon October 7, 2020 at 12:45 am
Today's Daily Dose brings you news about Axovant Gene's Parkinson's disease trial results, Corbus Pharma's cystic fibrosis trial data, Gamda's progress with Omidubicel, an investigational advanced ...
- Coffee may reduce risk for Parkinson's disease, study sayson October 6, 2020 at 12:28 am
Caffeine may reduce the risk of Parkinson's disease in people who have a gene mutation associated with the movement disorder, researchers report.
- Evidence of Alzheimer's, Parkinson's and MND in brains of young people exposed to dirty airon October 5, 2020 at 5:00 pm
Researchers looking at the brainstems of children and young adults exposed lifelong to air pollution in Mexico City have discovered disturbing evidence of harm.
- Could Coffee Reduce Parkinson's Risk?on October 5, 2020 at 2:52 pm
Caffeine may reduce the risk of Parkinson's disease in people who have a gene mutation associated with the movement disorder, researchers report. "These results are promising and encourage future ...
- Parkinson's patients face higher risk of dying from coronavirus, University of Iowa study suggestson October 5, 2020 at 7:13 am
People with Parkinson's disease may have a higher risk of death as a result of COVID-19, according to a new study published by researchers from the University of Iowa.
- Coffee may help protect you against Parkinson’son October 4, 2020 at 10:00 pm
Studies have shown drinking coffee might protect against the development of Parkinson’s disease in people who have no genetic risk factors for the disease. A new study, however, suggests coffee might ...
- Parkinson's: Study examines the potential of spinal cord stimulationon October 4, 2020 at 12:56 am
New research looks at whether methods of spinal cord stimulation could improve symptoms of Parkinson's disease — particularly pain and mobility issues.
- Promising “molecular tweezer” Parkinson’s therapy looks to human trialson October 3, 2020 at 5:00 pm
New research published in the journal Nature Communications reveals a novel drug, designed to break up the aggregations of toxic proteins associated with Parkinson’s disease, can effectively slow the ...
- Hiker tackles Parkinson's and Appalachian Trailon October 3, 2020 at 4:15 pm
After Dan Schoenthal was diagnosed with Parkinson's disease, he decided now is the time to finally accomplish a lifelong goal of hiking the Appalachian trail.
via Bing News